Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study.

Fujiwara D, Hino K, Yamaguchi Y, Kubo Y, Yamashita S, Uchida K, Konishi T, Nakamura H, Korenaga M, Okuda M, Okita K.

J Viral Hepat. 2004 Mar;11(2):136-40.

PMID:
14996348
2.

Expression of IFNAR2 mRNA in peripheral blood mononuclear cells of patients with HCV infection.

Liu N, Wen Y, Sun C, Liu P.

Acta Gastroenterol Belg. 2012 Jun;75(2):228-33.

PMID:
22870788
3.

Intrahepatic mRNA levels of type I interferon receptor and interferon-stimulated genes in genotype 1b chronic hepatitis C. Association between IFNAR1 mRNA level and sustained response to interferon therapy.

Taniguchi H, Iwasaki Y, Takahashi A, Shimomura H, Moriya A, Yu PC, Umeoka F, Fujioka S, Koide N, Shiratori Y.

Intervirology. 2007;50(1):32-9. Epub 2006 Nov 24.

PMID:
17164555
4.

Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.

Massirer KB, Hirata MH, Silva AE, Ferraz ML, Nguyen NY, Hirata RD.

Braz J Med Biol Res. 2004 May;37(5):643-7. Epub 2004 Apr 22.

5.
6.

Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection.

Morita K, Tanaka K, Saito S, Kitamura T, Kondo M, Sakaguchi T, Morimoto M, Sekihara H.

J Clin Gastroenterol. 1998 Mar;26(2):135-40.

PMID:
9563926
7.
8.

Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy.

Fukuda R, Ishimura N, Ishihara S, Tokuda A, Satoh S, Sakai S, Akagi S, Watanabe M, Fukumoto S.

J Gastroenterol. 1996 Dec;31(6):806-11.

PMID:
9027643
9.

Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients.

Mizukoshi E, Kaneko S, Yanagi M, Ohno H, Kaji K, Terasaki S, Shimoda A, Matsushita E, Kobayashi K.

J Med Virol. 1998 Nov;56(3):217-23.

PMID:
9783688
10.

Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.

Kessler HH, Pierer K, Santner BI, Vellimedu SK, Stelzl E, Marth E, Fickert P, Stauber RE.

J Hum Virol. 1998 Jul-Aug;1(5):314-9.

PMID:
10195258
11.
12.

Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C.

Ohata K, Yano K, Yatsuhashi H, Daikoku M, Koga M, Eguchi K, Yano M.

Dig Dis Sci. 2004 Feb;49(2):289-94.

PMID:
15104372
13.

Intrahepatic mRNA levels of interferon gamma and tumor necrosis factor alpha and response to antiviral treatment of chronic hepatitis C.

Dumoulin FL, Wennrich U, Nischalke HD, Leifeld L, Fischer HP, Sauerbruch T, Spengler U.

J Hum Virol. 2001 Jul-Aug;4(4):195-9.

PMID:
11694847
14.

Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.

Mizukoshi E, Kaneko S, Kaji K, Terasaki S, Matsushita E, Muraguchi M, Ohmoto Y, Kobayashi K.

Hepatology. 1999 Nov;30(5):1325-31.

PMID:
10534358
15.

Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.

Yamaguchi Y, Hino K, Fujiwara D, Ren F, Katoh Y, Satoh Y, Okita K.

Dig Dis Sci. 2002 Jul;47(7):1611-7.

PMID:
12141824
16.

Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.

GarcĂ­a-Bengoechea M, Basaras M, Barrio J, Arrese E, Montalvo II, Arenas JI, Cisterna R.

Am J Gastroenterol. 1999 Jul;94(7):1902-5.

PMID:
10406257
17.

Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.

Lee CM, Kee KM, Hung CH, Eng HL, Chang CH, Huang CM, Wang JH, Hu TH, Lu SN, Changchien CS, Chen WJ.

Antivir Ther. 2006;11(1):17-23.

PMID:
16518956
18.

IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.

Mathai J, Shimoda K, Banner BF, Mori M, Bonkovsky HL, Barnard GF.

J Interferon Cytokine Res. 1999 Sep;19(9):1011-8.

PMID:
10505743
19.

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.

Coppola N, Pisapia R, Tonziello G, Martini S, Imparato M, Piai G, Stanzione M, Sagnelli C, Filippini P, Piccinino F, Sagnelli E.

Antivir Ther. 2008;13(2):307-18.

PMID:
18505182

Supplemental Content

Support Center